Cornell’s Research
Serves the Region and Beyond

Acuamark Diagnostics, Inc. CTL

Early Detection Molecular Diagnostics

  • Products:
  • Eagle i5
  • Eagle iSEQ

Acuamark Diagnostics, Inc. develops technology that allows for the highly accurate screening of blood to detect cancer markers at the early cancer stages before the cancer becomes untreatable. The company is backed by a highly experienced team of scientific and business professionals. It is their mission to contribute to the global battle against cancer by detecting and attacking cancer through high precision, and early detection.

Cornell Connection

Acuamark Diagnostics' foundational technology was developed by a professor at Weill Cornell Medicine. The company's foundational technology is licensed from Cornell University.